Romero R, Horgan J G, Kohorn E I, Kadar N, Taylor K J, Hobbins J C
Obstet Gynecol. 1985 Oct;66(4):553-8.
The purpose of the study was to test the hypothesis of whether the combined use of ultrasound and human chorionic gonadotropin (hCG) determinations could increase the diagnostic accuracy of sonography in the diagnosis of hydatidiform mole. The criteria used were the absence of fetal heart movement by ultrasound when the hCG level was above 82,350 mIU/mL and the presence of an hCG level in excess of 2 SD above the mean for the biometrically derived gestational age for suspected partial moles. The threshold of 82,350 mIU/mL was derived by probit analysis of the hCG serum levels of a population of normal intrauterine pregnancies prospectively examined to determine the level of hCG at which fetal heart activity would be visible by sonography. The diagnostic accuracy of these criteria was compared with the preoperative sonographic examination in 36 hydatidiform moles. When sonography was used alone, 15 of 36 cases (41.6%) did not have a definitive diagnosis on the first examination. The combination of hCG and ultrasound would have correctly identified 32 of the 36 cases (88.8%). This improvement was statistically significant (P less than .005).
本研究的目的是检验超声检查联合人绒毛膜促性腺激素(hCG)测定能否提高超声诊断葡萄胎的准确性这一假设。所采用的标准为:当hCG水平高于82,350 mIU/mL时,超声检查未发现胎心搏动;对于疑似部分性葡萄胎,hCG水平超过根据生物测量得出的孕周均值2个标准差以上。82,350 mIU/mL这一阈值是通过对一组前瞻性检查的正常宫内妊娠人群的hCG血清水平进行概率分析得出的,以确定超声检查可见胎心活动时的hCG水平。将这些标准的诊断准确性与36例葡萄胎的术前超声检查结果进行了比较。单独使用超声检查时,36例中有15例(41.6%)在首次检查时未能明确诊断。hCG与超声联合应用可正确识别36例中的32例(88.8%)。这种改善具有统计学意义(P小于0.005)。